<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:bir="http://www.alacra.com/bir" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:srp="http://www.alacra.com/srp" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>Martek Biosciences Corporation RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Martek Biosciences Corporation</description>
<link>http://www.alacrastore.com/company-snapshot/Martek_Biosciences_Corporation-1078490</link>
<lastBuildDate>Tuesday, December 02, 2008 5:53:06 AM</lastBuildDate>
<alacra:xlsid>1078490</alacra:xlsid>
<alacra:company>Martek Biosciences Corporation</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-29669722</link><guid isPermaLink="false">newstex/PRN-0005-29669722</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> COLUMBIA, Md., Nov. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Martek Biosciences Corporation (Nasdaq: MATK), creator of the fast-growing life'sDHA(TM) brand of DHA (docosahexaenoic acid), today announced the launch of...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04007000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04007008</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04013000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04013002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14024000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14024002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">08003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04007003</newstex:cat><pubDate>11/18/2008 10:23:39 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Martek Marks Major Milestones: 100th Product Launched Featuring life'sDHA(TM); 15 Years on the NASDAQ</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-29669722</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MARTEK BIOSCIENCES CORP</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">STEVE NULL DUBIN</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MATK</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/bir/204319</link><guid isPermaLink="false">bir/204319</guid><bir:index_mode xmlns:bir="http://www.alacra.com/bir">norm</bir:index_mode><title>Martek Biosciences Corp.</title><bir:company xmlns:bir="http://www.alacra.com/bir">Martek Biosciences Corp.</bir:company><bir:company xmlns:bir="http://www.alacra.com/bir">Martek Corp.</bir:company><bir:cou xmlns:bir="http://www.alacra.com/bir">United States</bir:cou><bir:descr xmlns:bir="http://www.alacra.com/bir">Manufacturing: Manufactures micro algae biochemicals.</bir:descr><bir:sic xmlns:bir="http://www.alacra.com/bir">2836</bir:sic><bir:naics xmlns:bir="http://www.alacra.com/bir">325414</bir:naics><bir:class xmlns:bir="http://www.alacra.com/bir">17</bir:class><bir:size xmlns:bir="http://www.alacra.com/bir">E</bir:size><bir:revenue xmlns:bir="http://www.alacra.com/bir">I</bir:revenue><bir:ticker xmlns:bir="http://www.alacra.com/bir">MATK</bir:ticker><pubDate>10/18/2008 6:25:54 AM</pubDate><bir:docid xmlns:bir="http://www.alacra.com/bir">204319</bir:docid><category>Company Profiles &amp; Financials</category><alacra:ip>Gale Company Profiles</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1994009</link><guid isPermaLink="false">ccbn/T1994009</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - Canaccord Adams -  AnalystGood afternoon, everyone. Again, I'm Scott Van Winkle with Canaccord Adams, and I want to welcome you to the Martek  Biosciences presentation. Very happy to have the team here. From the company I have David Abramson, President as well as the Chief Financial Officer. If you notice, the stock has had a very good week thus far, and a name that we've recently recommended on Monday of this week; just I thought was a silly valuation, went down in the mid ##s. With that, I will turn it over to David. ...

</description><pubDate>10/15/2008 5:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Martek Biosciences Corporation</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Martek Biosciences Corporation at Canaccord Adams Healthy Living Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MATK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">2:00pm ET</ccbn:time><title>Martek Biosciences Corporation at Canaccord Adams Healthy Living Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1994009</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-28489957</link><guid isPermaLink="false">newstex/PRN-0005-28489957</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> COLUMBIA, Md., Oct. #, #### (PRNewswire-FirstCall delivered by Newstex) -- DHA omega-# innovator and maker of the life'sDHA(TM) brand, Martek Biosciences Corporation (Nasdaq: MATK), announced today that life'sDHA is featured in the...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14024000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14024002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">08003000</newstex:cat><pubDate>10/1/2008 4:23:34 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Martek's life'sDHA(TM) Featured in New Live Bright(TM) Brain Health Bar from Kellogg</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-28489957</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MARTEK BIOSCIENCES CORP</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">DAVID M ABRAMSON</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MATK</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-28279825</link><guid isPermaLink="false">newstex/PRN-0005-28279825</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> COLUMBIA, Md., Sep. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- (Nasdaq: MATK) -- Martek Biosciences Corporation announced today that it has entered into a multi-year sole source supply agreement with Grupo Ricap. Martek...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14024000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14024002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">08003000</newstex:cat><pubDate>9/24/2008 12:22:57 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002013</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002010</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Martek to be the Sole Source Supplier of DHA and ARA for Infant Formulas Produced By Grupo Ricap</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-28279825</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MARTEK BIOSCIENCES CORP</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MATK</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-28240089</link><guid isPermaLink="false">newstex/PRN-0005-28240089</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> COLUMBIA, Md., Sep. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- (Nasdaq: MATK) Martek Biosciences Corporation announced today that it has entered into a multi-year sole-source supply agreement with Hochdorf Nutricare AG...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14024000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14024002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04007000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04007003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">08003000</newstex:cat><pubDate>9/22/2008 5:21:44 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002007</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002018</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Martek is Now the Sole-Source Supplier of ARA for all Infant Formula Products Manufactured by Hochdorf Nutricare</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-28240089</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MARTEK BIOSCIENCES CORP</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MATK</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-28138747</link><guid isPermaLink="false">newstex/PRN-0005-28138747</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> COLUMBIA, Md., Sep. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it has entered into a multi-year DHA and ARA license and supply agreement with Hero, an international...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14024000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14024002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">08003000</newstex:cat><pubDate>9/18/2008 10:26:04 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002007</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Martek Signs Multi-Year Sole-Source Supply Agreement With Hero</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-28138747</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MARTEK BIOSCIENCES CORP</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MATK</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/B1944688</link><guid isPermaLink="false">ccbn/B1944688</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Growing infant formula revenues through increasing penetration in international infant formula markets. ...

</description><pubDate>9/4/2008 9:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Martek Biosciences Corporation</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Edited</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Martek Biosciences Corporation Q3 2008 Earnings Conference Call Summary</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MATK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:45pm ET</ccbn:time><title>Martek Biosciences Corporation Q3 2008 Earnings Conference Call Summary</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Brief</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">B1944688</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1944688</link><guid isPermaLink="false">ccbn/T1944688</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Ladies and gentlemen, thank you for standing by, and welcome to the Martek Biosciences third quarter earnings release conference call. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded Thursday, September #, ####. I would now like to turn the conference over to Mr. Peter Buzy, Chief Financial Officer. Please proceed sir. ...

</description><pubDate>9/4/2008 6:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Martek Biosciences Corporation</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Martek Biosciences Corporation Q3 2008 Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MATK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:45pm ET</ccbn:time><title>Martek Biosciences Corporation Q3 2008 Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1944688</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-27896865</link><guid isPermaLink="false">newstex/PRN-0005-27896865</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> COLUMBIA, Md., Sep. #, #### (PRNewswire-FirstCall delivered by Newstex) -- Martek Biosciences Corporation (Nasdaq: MATK) today announced its financial results for the third quarter of fiscal ####. Revenues for the third quarter were...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016047</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016013</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04013000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04013002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04007000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04007008</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14024000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14024002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014015</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">08003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04007003</newstex:cat><pubDate>9/4/2008 5:25:32 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18012000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18015000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002006</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002007</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Martek Announces Third Quarter 2008 Financial Results</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-27896865</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MARTEK BIOSCIENCES CORP</newstex:index_entry_company><newstex:index_entry_person xmlns:newstex="http://www.alacra.com/newstex">STEVE DUBIN</newstex:index_entry_person><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MATK</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-27883930</link><guid isPermaLink="false">newstex/PRN-0005-27883930</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> COLUMBIA, Md., Sep. #, #### (PRNewswire-FirstCall delivered by Newstex) -- Martek Biosciences (Nasdaq: MATK) announced today that Cabot Creamery Cooperative has introduced the new Cabot ##% Reduced Fat Cheddar Cheese with Omega-# DHA...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14024000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">14024002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">08003000</newstex:cat><pubDate>9/4/2008 10:27:31 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Martek's life'sDHA(TM) Featured in New Cabot Cheese Product</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-27883930</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">HEART HEALTH INC.</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">MARTEK BIOSCIENCES CORP</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">HHEL</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">MATK</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/B1862950</link><guid isPermaLink="false">ccbn/B1862950</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...From #Q## brought record quarterly revenues and pretax income into #Q##, outlook for #H## is for continued strong financial results. ...

</description><pubDate>6/4/2008 8:03:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Martek Biosciences Corporation</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Edited</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q2 2008 Martek Biosciences Corporation Earnings Conference Call Summary</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MATK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:45pm ET</ccbn:time><title>Q2 2008 Martek Biosciences Corporation Earnings Conference Call Summary</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Brief</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">B1862950</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1862950</link><guid isPermaLink="false">ccbn/T1862950</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Ladies and gentlemen, thank you for standing by. Welcome to the second quarter #### earnings conference call. During the presentation, all participants will be in a listen only mode. Afterwards we will conduct a question and answer session. (OPERATOR INSTRUCTIONS) As a reminder, this conference is being recorded Wednesday, June #, ####. It is now my pleasure to turn the conference over to Peter Buzy, Chief Financial Officer. Please go ahead. ...

</description><pubDate>6/4/2008 6:05:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Martek Biosciences Corporation</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q2 2008 Martek Biosciences Corporation Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MATK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:45pm ET</ccbn:time><title>Q2 2008 Martek Biosciences Corporation Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1862950</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/B1735567</link><guid isPermaLink="false">ccbn/B1735567</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Growing infant formula revenues through increasing penetration in the international infant formula markets....

</description><pubDate>3/5/2008 8:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Martek Biosciences Corporation</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Edited</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q1 2008 Martek Biosciences Corporation Earnings Conference Call Summary</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MATK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:45pm ET</ccbn:time><title>Q1 2008 Martek Biosciences Corporation Earnings Conference Call Summary</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Brief</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">B1735567</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1735567</link><guid isPermaLink="false">ccbn/T1735567</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Ladies and gentlemen, thank you for standing by. Welcome to the first quarter #### earnings conference call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will have a Q&amp;A session. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded Wednesday, March #, ####. It is now my pleasure to introduce Peter Buzy, Chief Financial Officer. Please go ahead, sir. ...

</description><pubDate>3/5/2008 8:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Martek Biosciences Corporation</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q1 2008 Martek Biosciences Corporation Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MATK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:45pm ET</ccbn:time><title>Q1 2008 Martek Biosciences Corporation Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1735567</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1701180</link><guid isPermaLink="false">ccbn/T1701180</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>12/31/2007 5:21:21 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Martek Biosciences Corporation</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q4 2007 Martek Biosciences Corporation Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MATK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:45pm ET</ccbn:time><title>Q4 2007 Martek Biosciences Corporation Earnings Conference Call Transcript</title><description>...Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to the fourth quarter #### earnings results conference call. (Operator Instructions). As a reminder, this conference is being recorded Wednesday, December ##, ####. It is now my pleasure to introduce Peter Buzy, Chief Financial Officer with Martek Biosciences. Please go ahead, sir. ...

</description><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1701180</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/B1701180</link><guid isPermaLink="false">ccbn/B1701180</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>12/31/2007 5:21:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Martek Biosciences Corporation</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Edited</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q4 2007 Martek Biosciences Corporation Earnings Conference Call Summary</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">MATK</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">4:45pm ET</ccbn:time><title>Q4 2007 Martek Biosciences Corporation Earnings Conference Call Summary</title><description>...Management reported #Q## income on a pretax basis of $##.#m, EPS of $#.##, pro forma EPS excluding the impact of a tax benefit and the restructuring charges of $#.##. Expects #Q## total revenues including non-infant formula related nutritional products sales of $#.#-#.#m to be $##-##m, and diluted EPS to be $#.##-#.##. ...

</description><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Brief</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">B1701180</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson StreetEvents</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/srp/23890</link><guid isPermaLink="false">srp/23890</guid><srp:index_mode xmlns:srp="http://www.alacra.com/srp">norm</srp:index_mode><description>...Address:#### Dobbin Road, Columbia, Maryland ##### Incorporated:DelawareWeb Site: www.martekbio.comSIC Classification: Biological Products, Except Diagnostic Substances (####) Business Description: Martek Biosciences Corporation develops, manufactures and sells naturally produced products derived from microalgae, fungi and other microbes. The company has pioneered the commercial development of high value products and product candidates consisting of nutritional products and fluorescent detection products. Indices:Russell ####, Russell ####, S&amp;P ### ...

</description><srp:company xmlns:srp="http://www.alacra.com/srp">23890</srp:company><title>Martek Biosciences Corporation</title><srp:cusip xmlns:srp="http://www.alacra.com/srp">572901106</srp:cusip><srp:ticker xmlns:srp="http://www.alacra.com/srp">MATK</srp:ticker><pubDate>10/6/2006 12:37:00 PM</pubDate><srp:docid xmlns:srp="http://www.alacra.com/srp">23890</srp:docid><category>Credit &amp; Investment Research</category><alacra:ip>SharkRepellent.net</alacra:ip></item></channel></rss>